Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.4M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
15.2M
-
Shares change
-
+148K
-
Total reported value, excl. options
-
$46.1M
-
Value change
-
+$443K
-
Number of buys
-
15
-
Number of sells
-
-10
-
Price
-
$3.02
Significant Holders of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) as of Q2 2025
34 filings reported holding IMDX - Insight Molecular Diagnostics Inc. - Common Stock as of Q2 2025.
Insight Molecular Diagnostics Inc. - Common Stock (IMDX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.2M shares
of 17.4M outstanding shares and own 87.55% of the company stock.
Largest 10 shareholders include BROADWOOD CAPITAL INC (11.4M shares), AWM Investment Company, Inc. (2.82M shares), VANGUARD GROUP INC (484K shares), GEODE CAPITAL MANAGEMENT, LLC (158K shares), BlackRock, Inc. (86.5K shares), MORGAN STANLEY (62.2K shares), Defender Capital, LLC. (32.9K shares), NORTHERN TRUST CORP (32.9K shares), CITADEL ADVISORS LLC (30.9K shares), and RENAISSANCE TECHNOLOGIES LLC (26.1K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.